Education
About Us
Working with TipRanks
Follow Us
Capstone Therapeutics Corp (CAPS)
NASDAQ:CAPS
CAPS Analyst Ratings
Hold
0 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CAPS Stock 12 Month Forecast
Average Price Target
$2.00
▲(47.06%Upside)
| Highest Price Target$2.00 | Average Price Target$2.00 | Lowest Price Target$2.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$1.5
Sell
10.29%
Upside
Reiterated
07/09/25
Capstone Therapeutics is hindered by severe financial challenges, including declining revenue, profitability, and negative equity, which significantly impacts its overall score. The technical analysis indicates bearish momentum, adding to the negative outlook. The poor valuation score due to negative earnings further exacerbates the stock's unattractiveness. While a corporate event suggests potential financial flexibility, it is not enough to offset the major financial and market challenges.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$1.5
Sell
10.29%
Upside
Reiterated
07/09/25
Capstone Therapeutics is hindered by severe financial challenges, including declining revenue, profitability, and negative equity, which significantly impacts its overall score. The technical analysis indicates bearish momentum, adding to the negative outlook. The poor valuation score due to negative earnings further exacerbates the stock's unattractiveness. While a corporate event suggests potential financial flexibility, it is not enough to offset the major financial and market challenges.
CAPS Analyst Recommendation Trends
Rating
May 25
Jun 25
Strong Buy
0
0
Buy
0
0
Hold
1
2
Sell
0
0
Strong Sell
0
0
total
1
2
Each month's total comprises the sum of three months' worth of ratings.
CAPS Financial Forecast
CAPS Stock Forecast FAQ
What is CAPS’s average 12-month price target, according to analysts?
Based on analyst ratings, Capstone Therapeutics Corp’s 12-month average price target is 2.00.
What is CAPS’s upside potential, based on the analysts’ average price target?
Capstone Therapeutics Corp has 47.06% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CAPS a Buy, Sell or Hold?
Capstone Therapeutics Corp has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Capstone Therapeutics Corp’s price target?
The average price target for Capstone Therapeutics Corp is 2.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $2.00 ,the lowest forecast is $2.00. The average price target represents 47.06% Increase from the current price of $1.36.
The highest analyst price target is $2.00 ,the lowest forecast is $2.00. The average price target represents 47.06% Increase from the current price of $1.36.
What do analysts say about Capstone Therapeutics Corp?
Capstone Therapeutics Corp’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of CAPS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.